Stacy Rudnicki MD
Neuromuscular Medicine, Neurophysiology
Professor, Neurology, University of Arkansas COM
Join to View Full Profile
4301 W Markham St # 783Little Rock, AR 72205
Phone+1 501-686-8000
Dr. Rudnicki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UMass Chan Medical SchoolResidency, Neurology, 1982 - 1986
Pennsylvania State University College of MedicineClass of 1982
Certifications & Licensure
AR State Medical License 1992 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Publications & Presentations
PubMed
- Hospitalizations as an outcome measure in COURAGE-ALS.Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, Adriano Chio, Philippe Corcia
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-06-12 - Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Ammar Al-Chalabi
JAMA Neurology. 2025-05-01 - 2 citationsPlasma neurofilament analysis in VITALITY-ALS.Tyrell J Simkins, Stuart Kupfer, Fady I Malik, Lisa Meng, Stacy A Rudnicki
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-02-01
Other
- Initial treatment of dermatomyositis and polymyositis in adultsRudnicki SA, Miller ML
http://www.uptodate.com/contents/initial-treatment-of-dermatomyositis-and-polymyositis-in-adults
UpToDate, Wolters Kluwer Health - 2012-11-05 - Treatment of recurrent and resistant dermatomyositis and polymyositis in adultsRudnicki SA, Miller ML
http://www.uptodate.com/contents/treatment-of-recurrent-and-resistant-dermatomyositis-and-polymyosit
UpToDate, Wolters Kluwer Health - 2013-04-12
Press Mentions
Cytokinetics Announces Five Presentations at the International Symposium on ALS/MNDNovember 26th, 2018- Cytokinetics Announces Presentations at the Cure SMA 2017 Annual SMA ConferenceDecember 1st, 2017
- Cytokinetics Announces Baseline Data from First Cohort of Phase 2 Clinical Trial of CK-2127107 in Patients with SMAJuly 5th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
